Lesotho vs Sao Tome and Principe: Estimated antiretroviral therapy coverage among people living with HIV
Lesotho
96.0%
in 2025
Sao Tome and Principe
97.0%
in 2025
Lesotho rank
4th
Sao Tome and Principe rank
2nd
Estimated antiretroviral therapy coverage among people living with HIV over time
- Lesotho
- Sao Tome and Principe
How they compare
Sao Tome and Principe currently reports 97.0% against 96.0% in Lesotho, a difference of 1.0%.
The two have swapped places 2 times across 26 shared years of data; in 2000 it was Sao Tome and Principe ahead.
Lesotho ranks 4th and Sao Tome and Principe ranks 2nd of 143 countries.
Across the 3 decades both report, Lesotho averaged higher in 2 and Sao Tome and Principe in 1.
Head to head by decade
| Decade | Lesotho | Sao Tome and Principe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.3% | 3.6% | 3.7% | Lesotho |
| 2010s | 51.6% | 49.9% | 1.7% | Lesotho |
| 2020s | 89.2% | 93.3% | 4.2% | Sao Tome and Principe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Lesotho or Sao Tome and Principe?
- Sao Tome and Principe, at 97.0% against 96.0% in Lesotho as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Lesotho and Sao Tome and Principe?
- 1.0%, with Sao Tome and Principe ahead.
- How many years of comparable data are there for Lesotho and Sao Tome and Principe?
- 26 years are reported by both, from 2000 to 2025.
- How do Lesotho and Sao Tome and Principe rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Lesotho ranks 4th and Sao Tome and Principe ranks 2nd of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.